Skåne unviersity Hospital
Lund, Skåne County, 22241, Sweden
Location status: Recruiting
NCT Number: NCT06153303
The primary aim of this study is to investigate the effect of Internet-delivered Acceptance and commitment therapy for endometriosis and chronic pain. A pilot study (no randomization; N=10) will be conducted to test the intervention and assessment procedures. The participants will go through an active internet-based ACT treatment focused on education about endometriosis and chronic pain, value-based exposure for avoided situations, and behavior change through exercises targeting the processes mindfulness, cognitive defusion and acceptance. The treatment is delivered on a safe internet platform. Participants have planned telephone contact with their assigned psychologist 2 times during the program and can also contact their psychologist via a message system in the platform and expect answer within 48 hours.
Interested in participating?
Request Info18 year–65 year
Female
Interventional
Not applicable
Lund, Skåne County, 22241, Sweden
Location status: Recruiting
Objective The primary aim of this study is to investigate the effect of Internet-delivered Acceptance and commitment therapy (iACT)for endometriosis.
Sample size 10 participants.
Trial design All participants are offered treatment. Participants are recruited from the Pain Rehabilitation Unit and the team for endometriosis at Skåne University Hospital. The unit is a government supported, regional specialist center focused on assessment and treatment of chronic pain and related disability.
Assessments Baseline and posttreatment (2 weeks after treatment) assessments will be conducted. Self-report measures will also be collected at baseline, post-treatment as well as during a 3-month follow up.
Assessment includes:Pre-and post assessment Assessors collected demographic information and self-report measures. During the pre-assessment the Mini International Neuropsychiatric Interview 5.0 (MINI) was administered to detect the presence of other comorbid disorders and assess inclusion criteria and rule out exclusion criteria.
During treatment During treatment the treatment credibility scale was administered to assess the patients' perceptions of how credible the treatment was following the introduction of the treatment rationale and the main treatment components (included in the internet program).
Safety parameters: As a mean to monitor safety and progress participants complete self-report measures (MPI, NRS, PIPS, PCS) and a question about suicidal ideation twice during the program and the therapist can follow these scores. In addition, participants can report any adverse events during treatment, at posttreatment and follow-up assessment.
Post-treatment exit interview At the post-assessment, the assigned assessor asked participants about their satisfaction with and experience of the program, what they found helpful or unhelpful and suggestions for future improvements.
Measures were taken at baseline, 2-weeks, 3 months follow-up. Self-report measures were mailed to participants
Main statistical analysis Between-group estimates on outcome will be conducted using repeated measurements. The analyses will be conducted using intention to treat principles and post hoc comparisons.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The participants will go through an active internet-based ACT treatment focused on education about endometriosis and chronic pain, value-based exposure for avoided situations, and behavior change through exercises targeting the processes mindfulness, cognitive defusion and acceptance. The treatment is delivered on a safe internet platform. Participants have planned telephone contact with their assigned psychologist 2 times during the program and can also contact their psychologist via a message system in the platform and expect answer within 48 hours.
Time frame: Baseline, mid-treatment (3 weeks), mid-treatment (5 weeks), two-week-post treatment, 3 month-follow- up
(changes between assessments) Min= 0; Max= 6. Higher scores indicate worse interference.
Time frame: Baseline, mid-treatment (3 weeks), mid-treatment (5 weeks), two-week-post treatment, 3 month-follow- up
(changes between assessments) (changes between assessments) Min=0; Max= 52. Higher scores indicate worse inflexibility
Time frame: Baseline, two-week-post treatment, 3 month-follow- up
(changes between assessments) Min= 0; Max= 21. Higher scores indicate worse depression/anxiety.
Time frame: Baseline, mid-treatment (3 weeks), mid-treatment (5 weeks), two-week-post treatment, 3 month-follow- up
(changes between assessments) Min= 0; Max= 10. Higher scores indicate worse pain intensity.
Time frame: Baseline, mid-treatment (3 weeks), mid-treatment (5 weeks), two-week-post treatment, 3 month-follow- up
(changes between assessments) Min= 0; Max= 52. Higher scores indicate worse pain catastrophizing.
Time frame: Baseline, two-week-post treatment, 3 month-follow- up
(changes between assessments)Min= 0; Max= 100. Lower scores indicate worse perceived health.
Time frame: Baseline, two-week-post treatment, 3 month-follow- up
(changes between assessments) Min= 17; Max= 68. Higher scores indicate worse kinesiophobia
Time frame: Baseline, 3 month-follow- up
(changes between assessments)
Time frame: Baseline, two-week-post treatment, 3 month-follow- up
(changes between assessments) Min=0; Max= 100. Lower scores indicate better health-related quality of life
Contact information is provided by the study sponsor or research team.
Skane University Hospital
Other
A Pilot Study of Internet-based ACT for Endometriosis and Chronic Pain
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06212349
Adherence Interventions, Behavior
Valencia, Spain
View Trial DetailsNCT07501182
Chronic Pain, Endometriosis
View Trial DetailsNCT07424859
Chronic Pain, Dysmenorrhea
São Paulo, Brazil
View Trial DetailsNCT02161302
Chronic Pain, Endometriosis
Porto Alegre, Rio Grande do Sul, Brazil
View Trial Details